Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶端-基底极性信号传导
基本信息
- 批准号:8649817
- 负责人:
- 金额:$ 6.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantApicalBiological AssayBrainBrain NeoplasmsCell ProliferationCell SeparationCell-Cell AdhesionCellsCessation of lifeCharacteristicsChildClinicalClinical ManagementClinical TreatmentComplementDataDefectDevelopmentDiagnosisDiseaseDrug DesignElementsEmbryoEpidermal Growth Factor ReceptorExcisionExhibitsGenesGlioblastomaGliomaGliomagenesisGoalsGrowthHourImmunocompromised HostIn VitroIndiumInvadedLateralLeadLightMalignant Childhood NeoplasmMalignant GliomaMalignant NeoplasmsMalignant neoplasm of brainMitosisModelingMolecularMolecular TargetMusNIH Program AnnouncementsNatureNeuraxisOncogenicOperative Surgical ProceduresOutcomePathologyPathway interactionsPatientsPlayPrimary NeoplasmPropertyRadiation therapyRecurrenceRegimenRelapseResistanceRoleSeedsSignal PathwaySignal TransductionSignal Transduction PathwaySliceSolid NeoplasmStem cellsSurvival RateSystemTestingTherapeuticTreatment ProtocolsTumor Cell InvasionTumor-DerivedUndifferentiatedUnited StatesVertebral columnXenograft ModelXenograft procedurebasebrain tissuecell growthcell motilitychemotherapydesigndrug discoveryglioma cell lineimplantationimprovedin vivoinnovationmigrationmortalityneoplastic cellnerve stem cellnovelnovel strategiesnovel therapeuticsoutcome forecastpre-clinicalpreventresearch studyself-renewalstemstem cell populationsubcutaneoustherapeutic targettumortumor growthwhite matter
项目摘要
Over 44,500 people in the United States are diagnosed with a primary tumor in the brain or spine each year. Of
this group, approximately 20,500 are diagnosed with primary malignant brain tumors. Brain tumors are also the
second most common cancer of childhood comprising approximately 25% of all pediatric cancers. It is the
leading cause of solid tumor cancer death in children. Mortality rates from brain tumors are extremely high,
with a median survival of approximately 12 months. Notably, mortality rates have remained unchanged over
the last two decades as malignant gliomas continue to present significant problems for successful clinical
treatment with the current regimen of surgery, radiotherapy or chemotherapy. The highly aggressive nature of
malignant gliomas - glioblastoma cells rapidly invade the surrounding brain parenchyma - stems from defects
in genes that control cell motility. Invasive tumor cells remaining after surgical resection confound clinical
management and significantly contribute to the lethality of this disease. Additionally, a chemotherapy and
radiotherapy resistant subpopulation of glioma cells retain stem cell-like properties to re-seed the tumor. This
leads to recurrence with even poorer prognosis. The glioma stem cell population may harbor defects in genes
that control self-renewal, proliferation and differentiation. Effective targeting of these invasive cells and the
stem cell population is critical for the improved management and positive clinical outcome in malignant
gliomas. The objective of this proposal is to determine if apical-basal polarity signaling is an important
molecular element in the invasive pathology and recurrence of gliomas. We have observed that altered apical-
basal polarity signaling causes the rapid proliferation and abnormal migration of undifferentiated cells bearing
markers of embryonic neural stem cells in the developing chick central nervous system. Based on this previous
study, we hypothesize that aberrant function of apical-basal polarity signaling pathway may play a central role
in the invasive progression and growth of glioblastoma. The specific aims of this proposal are: (i) to validate
our preliminary observation of a positive association between elevated apical-basal polarity signaling pathway
components and clinical glioblastoma, and to investigate the function of this pathway in glioma pathology. This
study is likely to elucidate the molecular function of apical-basal polarity signaling pathway in glioma invasion,
growth and progression, and provide the proof-of-concept for targeting this pathway as a novel strategy for
glioblastoma therapy. Our long-term goal is the rational targeting of this pathway in an improved therapeutic
paradigm for gliomas.
在美国,每年有超过 44,500 人被诊断患有脑部或脊柱原发性肿瘤。的
在这一群体中,大约有 20,500 人被诊断患有原发性恶性脑肿瘤。脑肿瘤也是
儿童第二常见癌症,约占所有儿科癌症的 25%。它是
儿童实体瘤癌症死亡的主要原因。脑肿瘤的死亡率极高,
中位生存期约为 12 个月。值得注意的是,死亡率多年来一直保持不变
在过去的二十年里,恶性神经胶质瘤继续给成功的临床带来重大问题
目前的治疗方案包括手术、放疗或化疗。高度攻击性的本质
恶性胶质瘤 - 胶质母细胞瘤细胞迅速侵入周围的脑实质 - 源于缺陷
控制细胞运动的基因。手术切除后残留的侵袭性肿瘤细胞混淆了临床
管理并极大地促进了这种疾病的致死率。此外,化疗和
放射治疗耐药的神经胶质瘤细胞亚群保留了干细胞样特性,可以重新播种肿瘤。这
导致复发,预后更差。神经胶质瘤干细胞群可能存在基因缺陷
控制自我更新、增殖和分化。有效靶向这些侵袭细胞和
干细胞群对于改善恶性疾病的治疗和积极的临床结果至关重要
神经胶质瘤。该提案的目的是确定顶端-基底极性信号传导是否是重要的
神经胶质瘤侵袭性病理学和复发中的分子因素。我们观察到改变了心尖-
基底极性信号导致未分化细胞快速增殖和异常迁移
发育中的雏鸡中枢神经系统中胚胎神经干细胞的标记。在此基础上
研究中,我们假设顶端-基底极性信号通路的异常功能可能发挥核心作用
胶质母细胞瘤的侵袭性进展和生长。该提案的具体目标是: (i) 验证
我们初步观察到顶端-基底极性信号通路升高之间存在正相关
成分和临床胶质母细胞瘤,并研究该通路在胶质瘤病理学中的功能。这
研究可能会阐明顶端-基底极性信号通路在神经胶质瘤侵袭中的分子功能,
生长和进展,并提供了将该途径作为一种新策略的概念验证
胶质母细胞瘤治疗。我们的长期目标是在改进的治疗中合理靶向该途径
神经胶质瘤的范例。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sourav Ghosh其他文献
Sourav Ghosh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sourav Ghosh', 18)}}的其他基金
Augmenting AXL and MERTK function to restrain cognitive decline and improve health span in mouse models of Alzheimer's Disease
增强 AXL 和 MERTK 功能以抑制阿尔茨海默氏病小鼠模型的认知衰退并改善健康寿命
- 批准号:
10662677 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Naïve T cell archetypes and anti-tumor immunity
幼稚 T 细胞原型和抗肿瘤免疫
- 批准号:
10741153 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Sex-Specific Single Cell Expression Profiles, Genetic Risk and Drug Responsiveness in Alzheimer's Disease
阿尔茨海默病的性别特异性单细胞表达谱、遗传风险和药物反应
- 批准号:
10467589 - 财政年份:2021
- 资助金额:
$ 6.56万 - 项目类别:
An innate immune checkpoint in cancer immunotherapy
癌症免疫治疗中的先天免疫检查点
- 批准号:
9447148 - 财政年份:2017
- 资助金额:
$ 6.56万 - 项目类别:
An innate immune checkpoint in cancer immunotherapy
癌症免疫治疗中的先天免疫检查点
- 批准号:
10286793 - 财政年份:2017
- 资助金额:
$ 6.56万 - 项目类别:
Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶端-基底极性信号传导
- 批准号:
8657870 - 财政年份:2010
- 资助金额:
$ 6.56万 - 项目类别:
Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶端-基底极性信号传导
- 批准号:
8461275 - 财政年份:2010
- 资助金额:
$ 6.56万 - 项目类别:
Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶底极性信号传导
- 批准号:
8817344 - 财政年份:2010
- 资助金额:
$ 6.56万 - 项目类别:
Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶底极性信号传导
- 批准号:
8915298 - 财政年份:2010
- 资助金额:
$ 6.56万 - 项目类别:
Apical-basal polarity signaling in glioblastoma
胶质母细胞瘤中的顶端-基底极性信号传导
- 批准号:
8527897 - 财政年份:2010
- 资助金额:
$ 6.56万 - 项目类别:
相似国自然基金
FGF8通过Ras/MEK/ERK信号通路调控apical ES结构影响精子生成的机制研究
- 批准号:81801519
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Changes in apical cochlear mechanics after cochlear implantation
人工耳蜗植入后耳蜗顶端力学的变化
- 批准号:
10730981 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Structural diversity of ceramide moiety responsible for apical membrane function of bladder transitional epithelial cells
负责膀胱移行上皮细胞顶膜功能的神经酰胺部分的结构多样性
- 批准号:
23K08792 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of photodynamic diagnosis for apical periodontitis based on 5-ALA fluorescence live imaging
基于5-ALA荧光实时成像的根尖周炎光动力诊断方法的建立
- 批准号:
23K09188 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Epithelial apical membrane polarization, morphogenesis, and regulation of gene expression
上皮顶膜极化、形态发生和基因表达调控
- 批准号:
BB/X000575/1 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Research Grant
Unveiling Functional Roles of Apical Surface Interactions Between Opposing Cell Layers
揭示相对细胞层之间顶端表面相互作用的功能作用
- 批准号:
10629101 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Cell-type specific assembly of apical extracellular matrices
顶端细胞外基质的细胞类型特异性组装
- 批准号:
10749768 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Evaluation of Trigeminal Ganglia Sensory Neuronal Population/s Mediating MIF-Induced Anti-Nociception in a Model of Apical Periodontitis.
根尖周炎模型中三叉神经节感觉神经元群介导 MIF 诱导的抗伤害感受的评估。
- 批准号:
10822712 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Exploring the role of phosphoinositides in the trafficking of proteins to the apical complex in the malaria parasite Plasmodium falciparum.
探索磷酸肌醇在疟原虫恶性疟原虫顶复合体蛋白质运输中的作用。
- 批准号:
495093 - 财政年份:2023
- 资助金额:
$ 6.56万 - 项目类别:
Operating Grants
Étude du rôle de la phosphatase de phosphoinositides SAC1 dans le trafic de protéines au complexe apical chez le parasite de la malaria Plasmodium falciparum
疟疾疟原虫顶端寄生虫复合物中磷酸肌醇磷酸酶 SAC1 的研究
- 批准号:
486094 - 财政年份:2022
- 资助金额:
$ 6.56万 - 项目类别:
Studentship Programs
Illuminating apical extracellular matrix structure and biogenesis
阐明顶端细胞外基质结构和生物发生
- 批准号:
10654029 - 财政年份:2022
- 资助金额:
$ 6.56万 - 项目类别: